Sort
23,748 grants matching “melanoma”
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
$427,942Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Community Outreach and Engagement
$427,923Pamela Carmen Hull · University Of Kentucky · P30 · FY2024 · CA
DELINEATING GERMLINE, TUMOR AND EXTRINSIC FACTORS DRIVING MUCOSAL MELANOMA RISK AND RESPONSE
$427,817The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2022 · Department of the Army
Targeting the Rac1 signaling pathway in malignant melanoma
$427,763Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · R01 · FY2021 · CA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$427,661Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · CA
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
$427,625Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R21 · FY2023 · NS
Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines
$427,406Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
Rewired Metabolism Regulates Vessel Normalization and Immunosuppression
$427,384Xiang Zhang · Baylor College Of Medicine · R01 · FY2019 · CA
Histone Arginine Demethylation through Cleavage
$427,284Gongyi Zhang · National Jewish Health · R01 · FY2022 · GM
Molecular Epidemiology of Non-Melanoma Skin Cancer
$427,190Heather Nelson · University Of Minnesota · R01 · FY2009 · CA
Prostate Pre-Clinical
$427,146Fred W Hetzel · University Of Colorado Denver · P01 · FY2008 · CA
MURINE P73 IN TUMORIGENESIS
$427,110Harvard University (Medical School) · R01 · FY2000 · CA
Insights into Structure-Function Relationships of Matrix Metalloproteinase-1 from Computational and Experimental Studies
$427,001Tatyana Karabencheva-Christova · Michigan Technological University · R15 · FY2023 · GM
Biostatistics Facility
$426,983Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
Targeting exosomal PDL1 to improve immunotherapy
$426,960Wei Guo · Wistar Institute · P50 · FY2024 · CA
Biostatistics Facility
$426,925Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2015 · CA
Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma
$426,856Jeffrey M. Trent · Translational Genomics Research Inst · R01 · FY2007 · CA
The mutational mechanisms shaping melanocytes in human skin
$426,693Alan Hunter Shain · University Of California, San Francisco · R01 · FY2023 · AR
Define the Role of POT1 Mutation in Genome Instability and Cancer
$426,664Agnel Sfeir · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
HSP70 and melanoma
$426,316Maureen E Murphy · Wistar Institute · R01 · FY2019 · CA
Identification of Common Polymorphisms Affecting Angiogenesis
$426,300Robert J D'amato · Boston Children'S Hospital · R01 · FY2015 · EY
Identification of Common Polymorphisms Affecting Angiogenesis
$426,300Robert J D'amato · Boston Children'S Hospital · R01 · FY2014 · EY
Targeting TERT in Melanoma
$426,277Jessie Villanueva · Wistar Institute · R01 · FY2019 · CA
Solar Exposure and Melanoma Survival
$426,227Marianne Berwick · University Of New Mexico · R01 · FY2008 · CA
Dual-pronged nano-drug delivery using plant virus-like particles.
$426,217Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2021 · CA